MovDisordV3, France, Analysis, bibRecord, 000302

Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome

Identifieur interne : 000302 ( France/Analysis ); précédent : 000301; suivant : 000303

Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome

Auteurs : Mouna Ben Djebara [France] ; Yulia Worbe [France] ; Michael Schüpbach [France] ; Andreas Hartmann [France]

Source :

Movement Disorders [ 0885-3185 ] ; 2008-02-15.

RBID : ISTEX:0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A

Descripteurs français

Pascal (Inist)
- Aripiprazole, Coprolalie, Pathologie du système nerveux, Syndrome de Gilles de la Tourette.

English descriptors

KwdEn :
- Adult, Antipsychotic Agents (therapeutic use), Aripiprazole, Coprolalia, Gilles de la Tourette syndrome, Humans, Male, Nervous system diseases, Piperazines (therapeutic use), Quinolones (therapeutic use), Tourette Syndrome (drug therapy), Treatment Outcome, aripiprazole, coprolalia.
MESH :
- chemical , therapeutic use : Antipsychotic Agents, Piperazines, Quinolones.
- drug therapy : Tourette Syndrome.
- Adult, Humans, Male, Treatment Outcome.

Abstract

Coprolalia is one of the most distressing symptoms in Gilles de la Tourette syndrome. We report on a 28‐year‐old man with severe coprolalia at the forefront of symptoms, which had a dramatic impact on his social and professional life and that did not fluctuate for years. Moreover, he presented hypersensitivity to neuroleptics. The use of aripiprazole, as a last resort, induced a 75% of improvement of his symptoms with good tolerance. This suggests that aripiprazole constitutes a valuable therapeutic in coprolalia. Moreover, its biochemical class specificity makes it an alternative for patients hypersensitive to other classes of neuroleptics. © 2007 Movement Disorder Society

Url:

https://api.istex.fr/document/0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A/fulltext/pdf

DOI: 10.1002/mds.21859

Affiliations:

Links to Exploration step

ISTEX:0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome</title>
<author><name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
</author>
<author><name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
</author>
<author><name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
</author>
<author><name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21859</idno>
<idno type="url">https://api.istex.fr/document/0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003502</idno>
<idno type="wicri:Area/Istex/Curation">003502</idno>
<idno type="wicri:Area/Istex/Checkpoint">001551</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ben Djebara M:aripiprazole:a:treatment</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18067182</idno>
<idno type="wicri:Area/PubMed/Corpus">002408</idno>
<idno type="wicri:Area/PubMed/Curation">002408</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002428</idno>
<idno type="wicri:Area/Ncbi/Merge">001F51</idno>
<idno type="wicri:Area/Ncbi/Curation">001F51</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001F51</idno>
<idno type="wicri:Area/Main/Merge">003573</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0169590</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001322</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001520</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001997</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001013</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ben Djebara M:aripiprazole:a:treatment</idno>
<idno type="wicri:Area/Main/Merge">003621</idno>
<idno type="wicri:Area/Main/Curation">002993</idno>
<idno type="wicri:Area/Main/Exploration">002993</idno>
<idno type="wicri:Area/France/Extraction">000302</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome</title>
<author><name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>AP‐HP, Pitié‐Salpêtrière Group, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>AP‐HP, Pitié‐Salpêtrière Group, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>AP‐HP, Pitié‐Salpêtrière Group, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>AP‐HP, Pitié‐Salpêtrière Group, Fédération de Neurologie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, Université Pierre et Marie Curie, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-02-15">2008-02-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="438">438</biblScope>
<biblScope unit="page" to="440">440</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A</idno>
<idno type="DOI">10.1002/mds.21859</idno>
<idno type="ArticleID">MDS21859</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Aripiprazole</term>
<term>Coprolalia</term>
<term>Gilles de la Tourette syndrome</term>
<term>Humans</term>
<term>Male</term>
<term>Nervous system diseases</term>
<term>Piperazines (therapeutic use)</term>
<term>Quinolones (therapeutic use)</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Treatment Outcome</term>
<term>aripiprazole</term>
<term>coprolalia</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Piperazines</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Aripiprazole</term>
<term>Coprolalie</term>
<term>Pathologie du   système nerveux</term>
<term>Syndrome de Gilles de la Tourette</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Coprolalia is one of the most distressing symptoms in Gilles de la Tourette syndrome. We report on a 28‐year‐old man with severe coprolalia at the forefront of symptoms, which had a dramatic impact on his social and professional life and that did not fluctuate for years. Moreover, he presented hypersensitivity to neuroleptics. The use of aripiprazole, as a last resort, induced a 75% of improvement of his symptoms with good tolerance. This suggests that aripiprazole constitutes a valuable therapeutic in coprolalia. Moreover, its biochemical class specificity makes it an alternative for patients hypersensitive to other classes of neuroleptics. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
<orgName><li>Université Pierre-et-Marie-Curie</li>
</orgName>
</list>
<tree><country name="France"><noRegion><name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
</noRegion>
<name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
<name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
<name sortKey="Ben Djebara, Mouna" sort="Ben Djebara, Mouna" uniqKey="Ben Djebara M" first="Mouna" last="Ben Djebara">Mouna Ben Djebara</name>
<name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
<name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
<name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
<name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name>
<name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
<name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
<name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
<name sortKey="Worbe, Yulia" sort="Worbe, Yulia" uniqKey="Worbe Y" first="Yulia" last="Worbe">Yulia Worbe</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000302 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000302 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:0D9D91ED59AA4281F9AEE5B48EF0248C77CB833A
   |texte=   Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome

Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.